| Issue |
Med Sci (Paris)
Volume 21, Number 1, Janvier 2005
|
|
|---|---|---|
| Page(s) | 22 - 24 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/200521122 | |
| Published online | 15 January 2005 | |
Rod-derived cone viability factor : un espoir de thérapie des dégénérescences rétiniennes ?
Rod-derived cone viability factor: a clue for therapy of retinitis pigmentosa ?
1
Inserm U.592, Laboratoire de Physiopathologie cellulaire et moléculaire de la rétine, Université Pierre et Marie Curie, Hôpital Saint-Antoine, Bâtiment Kourilsky, 184, rue du Faubourg Saint-Antoine, 75571 Paris Cedex 12, France
2
Institut de Génétique et de biologie moléculaire et cellulaire, BP 163, 67404 Illkirch Cedex, CU de Strasbourg, France
*
leveilla@st-antoine.inserm.fr
Cet article ne possède pas de résumé.
© 2005 médecine/sciences - Inserm / SRMS
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
